Skip to main content
OpenTrials

Clinical trial condition

Relapsed Solid Tumors

Explore clinical trials studying Relapsed Solid Tumors. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Solid Tumors trial results

Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions
Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

KSH01-TCRT Solid Tumors

NCT05539833

Conditions
Refractory Solid Tumors, Relapsed Solid Tumors, TCR-T Cells
Locations
  • The first affiliated hospital of Guang Xi medical university Nanning, Guangxi, China
View Trial Details
Completed

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

NCT02512926

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions